NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Document center

A hand picked selection of interesting presentations and info

Evaluation study of the European framework programmes for research and innovation for excellent science - Horizon 2020 : phase 1 final study report

Published on | 1 year ago

Programmes ERC   RI   MSCA   FET   Widening   SwafS  

The study presents lessons learned and recommendations for policy on excellent science under Horizon 2020. This is one of several support studies feeding into the European Commission's ex-post evaluation of the European framework programme for Research and Innovation Horizon 2020.

This evaluation study, performed in line with the Better Regulation Guidelines, serves as an input into the ex-post evaluation of Horizon 2020, the EU framework programme for Research and Innovation 2014-2020. Horizon 2020 was adopted in the context of the Europe 2020 Strategy, and was designed to drive economic growth and create jobs by coupling research and innovation (R&I), with an emphasis on excellent science, industrial leadership and tackling societal challenges. This study assesses the overall contribution of Horizon 2020 to excellent science across the framework programme with a particular focus on the activities under Pillar 1, Excellent Science (i.e. the European Research Council (ERC), Marie Skłodowska-Curie Actions (MSCA), European research infrastructures (INFRA), and Future and Emerging Technologies (FET)), as well as the horizontal pillars Spreading Excellence and Widening Participation (SEWP) and Science with and for Society (SwafS). The study builds on the Horizon 2020 intervention logic and relies on a wide range of methods. These include (but are not limited to) desk research, a broad-scope interview programme, 15 case studies and four international benchmark studies, a survey programme, a bibliometric analysis, econometric modelling, and the analysis of (unstructured and EC monitoring) data. The findings of the study respond to a set of evaluation questions covering the five evaluation criteria: relevance, coherence, efficiency, effectiveness and EU added value. This study places a stronger focus on the key findings, conclusions and recommendations in relation to efficiency, effectiveness and EU added value, as the other evaluation criteria are analysed in greater depth by other ongoing studies. (from the executive summary)

myOVERVIEW
- sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.